## VRSK: Verisk Analytics, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -1.6% below STRENGTH zone (4.0-10.0%); PEG 2.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($210.04)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Perpetual Ltd Decreases Stock Holdings in Verisk Analytics, Inc. $VRSK**
- Source: MarketBeat | 20251221T111028 | Neutral | Relevance: 100%
- Perpetual Ltd significantly reduced its stake in Verisk Analytics ($VRSK) by 58.5% in Q3 2025, selling 8,867 shares and retaining 6,297 shares valued at $1.584 million. While Verisk beat EPS estimates in Q3, it missed revenue forecasts and provided FY2025 EPS guidance. Despite institutional ownership of around 90%, company insiders, particularly directors Gregory Hendrick and Sabra Purtill, also bought shares, although overall insider selling outnumbered buying last quarter.

**2. Douglas Lane & Associates LLC Purchases 24,657 Shares of Verisk Analytics, Inc. $VRSK**
- Source: MarketBeat | 20251221T093154 | Somewhat-Bullish | Relevance: 100%
- Douglas Lane & Associates LLC significantly increased its stake in Verisk Analytics, Inc. (NASDAQ:VRSK) by 561.0% in the third quarter, acquiring an additional 24,657 shares to hold a total of 29,052 shares valued at $7.31 million. Insider transactions showed directors purchasing shares, while analyst ratings provide a consensus "Hold" with an average price target of $278.64. Verisk Analytics slightly exceeded Q3 EPS expectations and provided FY2025 guidance of $6.80â€“$7.00 per share.

**3. USA Financial Formulas Has $353,000 Stake in Verisk Analytics, Inc. $VRSK**
- Source: MarketBeat | 20251221T132737 | Neutral | Relevance: 100%
- USA Financial Formulas significantly reduced its stake in Verisk Analytics (NASDAQ:VRSK) by 85.2% during Q3, retaining 1,403 shares valued at approximately $353,000. Despite mixed analyst sentiment leading to a consensus "Hold" rating and a mean price target of $278.64, Verisk reported strong Q3 EPS of $1.72, beating estimates, and declared a quarterly dividend of $0.45. Insider transactions also showed some buying activity by directors.

**4. Riverbridge Partners LLC Has $78.04 Million Stake in Verisk Analytics, Inc. $VRSK**
- Source: MarketBeat | 20251222T130205 | Neutral | Relevance: 97%
- Riverbridge Partners LLC recently trimmed its stake in Verisk Analytics (NASDAQ:VRSK) by 1.5% to 310,275 shares, valued at $78.04 million. Despite this, other major institutional investors like Norges Bank, UBS, Goldman Sachs, and Arrowstreet Capital significantly increased their positions, collectively bringing institutional ownership to about 90%. Analysts maintain a "Hold" rating on Verisk Analytics, with an average price target of $278.64, while the company reported strong quarterly earnings and issued optimistic FY2025 guidance.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $270 | $290 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.31M) |
| Sells | 5 ($0.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (+2.0%)
- Blackrock Inc.: 9.4% (+5.5%)
- State Street Corpora: 4.3% (-1.3%)
- Alliancebernstein L.: 3.8% (+3.1%)
- FMR, LLC: 3.1% (-22.9%)

### Key Risks

1. Long-term trend broken: trading 19.2% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.68 signals overvaluation risk, limited margin of safety. Forward P/E 28.5x stretched relative to 10% growth. Quality metrics strong (ROE 268%, ROA 16%, margin 30%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $30.5B |
| Beta | 0.81 |
| 52W Range | $197.00 - $322.92 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.68 |
| Forward P/E | 28.5 |
| Current P/E | 31.5 |
| YoY Growth | 10.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.4% to -1.6% (-3.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.6pp (needs >4.0% for momentum thesis). Below SMA200 (0.81x), long-term trend not supportive. RSI neutral at 46. Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.61% (CS: 36) | Neutral |
| RSI_14 | 45.9 | Neutral |
| MACD Histogram | 0.37 | Bullish |
| vs SMA20 | 0.993x | Below |
| vs SMA50 | 0.982x | Below |
| vs SMA200 | 0.808x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $218.46
- **Stop Loss:** $210.04 (3.9% risk)
- **Target:** $226.88 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 106
- **Position Value:** $23,156.76
- **Portfolio %:** 23.16%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-25 (Est: $1.61)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.70 | $1.72 | +1.0% |
| 2025Q2 | $1.77 | $1.88 | +6.1% |
| 2025Q1 | $1.68 | $1.73 | +2.8% |
| 2024Q4 | $1.60 | $1.61 | +0.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*